ImmPort Study ID	PubMed	Study Title	PI	Biosample ID	Experiment ID	Cohort	Repository Accession	Type	Subtype	Biosample Name	Biosample Description	Species	Strain	Cancer Type	Tissue	Cell Type	Cell Line	Treatment
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944217	Melanoma	Cutaneous Melanoma (SKCM)	2117	sample name: s2117_B	Mus musculus	2117	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944218	Melanoma	Cutaneous Melanoma (SKCM)	2118	sample name: s2118_B	Mus musculus	2118	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944219	Melanoma	Cutaneous Melanoma (SKCM)	2124	sample name: s2124_B	Mus musculus	2124	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944220	Melanoma	Cutaneous Melanoma (SKCM)	2125	sample name: s2125_B	Mus musculus	2125	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944221	Melanoma	Cutaneous Melanoma (SKCM)	2130	sample name: s2130_B	Mus musculus	2130	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944222	Melanoma	Cutaneous Melanoma (SKCM)	2131	sample name: s2131_B	Mus musculus	2131	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944223	Melanoma	Cutaneous Melanoma (SKCM)	2135	sample name: s2135_B	Mus musculus	2135	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944224	Melanoma	Cutaneous Melanoma (SKCM)	2139	sample name: s2139_B2	Mus musculus	2139	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944225	Melanoma	Cutaneous Melanoma (SKCM)	2140	sample name: s2140_B	Mus musculus	2140	Melanoma	None	B16 F1	None	IgG
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944226	Melanoma	Cutaneous Melanoma (SKCM)	2142	sample name: s2142_B	Mus musculus	2142	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944227	Melanoma	Cutaneous Melanoma (SKCM)	2144	sample name: s2144_B	Mus musculus	2144	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
GSE109485	29386395	Anti-PD-1/anti-CTLA-4 efficacy in melanoma brain metastases depends on extracranial disease and augmentation of CD8+ T cell trafficking	Brain metastasis group	SRX3591537	GSE109485	Intracranial tumor	GSM2944228	Melanoma	Cutaneous Melanoma (SKCM)	2147	sample name: s2147_B	Mus musculus	2147	Melanoma	None	B16 F1	None	anti-PD-1 plus anti-CTLA-4
